Nisha De Silva

492 total citations
2 papers, 26 citations indexed

About

Nisha De Silva is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Nisha De Silva has authored 2 papers receiving a total of 26 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Genetics, 2 papers in Immunology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Nisha De Silva's work include Immunodeficiency and Autoimmune Disorders (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lymphoma Diagnosis and Treatment (1 paper). Nisha De Silva is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lymphoma Diagnosis and Treatment (1 paper). Nisha De Silva collaborates with scholars based in Germany. Nisha De Silva's co-authors include Moritz Fürstenau, Barbara Eichhorst, Michael Hallek, Eugen Tausch, Paula Cramer, Karl‐Anton Kreuzer, Clemens‐Martin Wendtner, Othman Al‐Sawaf, Anna Maria Fink and Thomas Illmer and has published in prestigious journals such as Blood and HemaSphere.

In The Last Decade

Nisha De Silva

2 papers receiving 26 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nisha De Silva Germany	2	23	22	10	8	4	2	26
Tatiana Chagorova Australia	2	28 1.2×	28 1.3×	8 0.8×	5 0.6×	6 1.5×	3	32
Stephan DiSean Kendall United States	2	19 0.8×	16 0.7×	6 0.6×	5 0.6×	2 0.5×	2	20
Allison M. Booth United States	4	15 0.7×	11 0.5×	6 0.6×	9 1.1×	5 1.3×	8	23
Valentina Ivanova Russia	4	30 1.3×	33 1.5×	9 0.9×	4 0.5×	5 1.3×	9	43
Sophia Sohoni United States	2	27 1.2×	23 1.0×	6 0.6×	9 1.1×	3 0.8×	3	35
Adriana Perilla-Glen United States	3	24 1.0×	23 1.0×	10 1.0×	10 1.3×		4	33
Narasimha Marella Australia	2	15 0.7×	13 0.6×	2 0.2×	5 0.6×	2 0.5×	2	16
Jan Duerig Germany	4	22 1.0×	20 0.9×	5 0.5×	13 1.6×	7 1.8×	12	34
Kaitlin Kennard United States	3	15 0.7×	15 0.7×	4 0.4×	8 1.0×	1 0.3×	9	25
Zoltán Gasztonyi Hungary	3	10 0.4×	8 0.4×	8 0.8×	16 2.0×		7	22

Countries citing papers authored by Nisha De Silva

Since Specialization

Citations

This map shows the geographic impact of Nisha De Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nisha De Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nisha De Silva more than expected).

Fields of papers citing papers by Nisha De Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nisha De Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nisha De Silva. The network helps show where Nisha De Silva may publish in the future.

Co-authorship network of co-authors of Nisha De Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Nisha De Silva. A scholar is included among the top collaborators of Nisha De Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nisha De Silva. Nisha De Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Fürstenau, Moritz, Nisha De Silva, Barbara Eichhorst, & Michael Hallek. (2019). Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?. HemaSphere. 3(5). e287–e287. 25 indexed citations

2.

Tresckow, Julia von, Paula Cramer, Nisha De Silva, et al.. (2019). Sequential Treatment with Bendamustine, Obinutuzumab (GA101) and Ibrutinib in Chronic Lymphocytic Leukemia (CLL): Final Results of the CLL2-BIG Trial of the German CLL Study Group (GCLLSG). Blood. 134(Supplement_1). 3046–3046. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact